3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 4
1
Phase 3
1
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Lymphoma, Non-Hodgkin
2
Immunoglobulin Light-chain Amyloidosis
2
Colorectal Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Breast Neoplasms
2
Amyloidosis
2
Waldenstrom Macroglobulinemia
1
Tissue Adhesions
1
Skin Toxicity
1
Sezary Syndrome
1
Ras-wildtype Colorectal Cancer
1
Polyps
1
Pleural Effusion, Malignant
1
Pancreatic Neoplasms
1
Pain
1
Myoma
1
Mycosis Fungoides
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, T-Cell
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Head and Neck Neoplasms
1
Exanthema
1
Endometritis
1
Amyloidosis, Familial
1
Advanced Malignant Neoplasm
1
AA amyloidosis
1
Interventions
Paclitaxel
5
Carboplatin
5
Docetaxel
4
Cisplatin
4
Bevacizumab
4
Taxes
3
Drug Therapy
3
Gemcitabine
2
Fluorodeoxyglucose F18
2
Cetuximab
2
saracatinib
1
endostar protein
1
cediranib
1
aflutinib
1
Zoledronic Acid
1
X-Rays
1
Vinorelbine
1
Thoracic Surgery, Video-Assisted
1
Spectrum Analysis
1
Silver Nitrate
1
Saline Solution
1
Radiotherapy, Conformal
1
Radiation
1
Pleurodesis
1
Pemetrexed
1
Nivolumab
1
Naproxen
1
N-(5-(2,3-dihydrobenzofuryl)sulfonyl)-N'-(3,4-dichlorophenyl)urea
1
Morphine
1
Metformin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Pleural Effusion, Malignant
×
Doxycycline
×
Clear all
NCT01411202
2020-09-25
OPUS
Ottawa Hospital Research Institute
Phase 2
Unknown
40 enrolled